¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10
±³À°ÀÏÀÚ : 2023-05-10
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º, ±×·£µåº¼·ë(5F)

±³À°ÁÖÁ¦ : IASS 2023 (Çмú´ëȸ)

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ

´ã´çÀÚ : ÃÖ°æ¼ö
¿¬¶ôó : 02-2038-7674

À̸ÞÀÏ : IASS2022@humming.co.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 500,000¿ø  

ºñ°í ÇǺΰú Àü¹®ÀÇ : 5¸¸¿ø·¹Áö´øÆ®, ¿¬±¸¿ø : 2¸¸¿øºñȸ¿ø : 50¸¸¿ø

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:20~09:40 What¡¯s new in itch mechanism and therapeutic approaches for atopic dermatitis? Jiehyun Jeon(Korea Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:40~10:00 Characteristics for pediatric atopic dermatitis : What¡¯s the different  adult atopic dermatitis? Sang Eun Lee(Yonsei Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:00~10:20 Understanding of skin microbiome in atopic dermatitis for advance atopic dermatitis treatment Jihyun Lee(Catholic Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:20~10:30 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:30~11:10 Introduction of the concept of minimal disease activity Mark Kirchhof(Ottawa Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:10~11:20 Q&A ( )

ÈÞ½Ä 05¿ù 10ÀÏ 11:20~11:35 Coffee Break ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:35~12:15 Can treatment impact the natural course of atopic dermatitis and comorbidity? Eric simpson(Oregon Health and Science Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:15~12:25 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:25~12:45 Prominent role of type 2 inflammation in skin diseases: beyond atopic dermatitis (Jiyoung Ahn)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:45~12:55 Q&A ( )

½Ä»ç 05¿ù 10ÀÏ 12:55~13:20 Lunch ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 13:20~14:00 Current learning on the applications of atopic dermatitis therapy in real-world practice Stephan Weidinger(Christian-Albrechts Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:00~14:10 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:10~14:50 How does baricitinib real-world evidence compare to randomized controlled trials? Andreas Wollenberg(Ludwig-Maximilian Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:50~15:00 Q&A ( )

ÈÞ½Ä 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:00~15:15 Coffee Break ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:15~15:55 Long-term perspectives in atopic dermatitis Chih-Ho Hong(British Columbia Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:55~16:05 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:05~16:25 Treat-to-target in atopic dermatitis : an important strategy for successful treatment Chan Ho Na(Chosun Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:25~16:45 Optimal use of JAK inhibitors for atopic dermatitis based on real-world experiences Min Kyung Shin(Kyung Hee Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:45~17:05 Update on the treatment of pediatric atopic dermatitis Jung-Im Na(Seoul National Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 17:05~17:15 Q&A ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѺñ´¢ÀÇÇÐȸ Á¦306ȸ Çмú´ëȸ(½ÅÀå¾Ï, ¹æ°ü¾Ï) : 2023-05-11
´ÙÀ½±Û ´ë»óÆ÷Áø ¹é½ÅÀÇ ÃÖ½ÅÁö°ß : 2023-05-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
189 ¼­¿ï °­ºÏ»ï¼ºº´¿ø ¾È°úÇб³½Ç ½ÉÆ÷Áö¾ö : 2018-09-01 0 643 2018-07-28
188 ºÎ»ê 2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(9¿ù 1ÀÏ) : 2018-09-01 0 546 2018-07-28
187 Á¦ÁÖ ´ëÇÑ°£ÇÐȸ °£Áúȯ ÃֽŠÁö°ß update : 2018-09-01 0 389 2018-07-28
186 ¼­¿ï ´ëÇѺñ´¢±â°úÇÐȸ 2018 KPS-APSU Joint International Symposium : 2018-09-01 0 615 2018-07-28
185 °­¿ø ´ëÇѽŻý¾ÆÇÐȸ Á¦9Â÷ ±³À°¼¼¹Ì³ª ¥± : 2018-09-01 0 369 2018-07-28
184 °æ³² 2018 ºÎ»ê¿ï»ê°æ³² ¼Ò¾Æ½Å°æÁöȸ ½ÉÆ÷Áö¾ö: IMPROVING MANAGEMENT SKILLS IN PEDIATRIC NEUROLOGY : 2018-09-01 0 630 2018-07-28
183 ¼­¿ï 2018³âµµ Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¦10ȸ Àü°øÀǸ¦ À§ÇÑ Á¤½ÅÄ¡·á ¿öÅ©¼ó : 2018-09-01 0 769 2018-07-28
182 °æ±â Á¦1ȸ ¸íÁöº´¿ø ½Å°æ°ú ½ÉÆ÷Áö¾ö -ÀÏÂ÷Áø·á¿¡¼­ ÈçÈ÷ Á¢ÇÏ´Â ½Å°æ°ú Áúȯ : 2018-09-01 0 758 2018-07-28
181 °­¿ø 2018³â ´ëÇѺ¸Á¶»ý½ÄÇÐȸ Á¦32Â÷ Çмú´ëȸ : 2018-09-01 0 734 2018-07-28
180 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ÀΰÝÀå¾Ö¶õ ¹«¾ùÀΰ¡? : 2018-09-01 0 656 2018-07-28
179 ¿ï»ê ¿ï»ê½Ã°³¿ø³»°úÀÇ»çȸ Ãß°èÇмú´ëȸ : 2018-09-01 0 758 2018-07-28
178 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ 2018³â Hanyang foot & ankle symposium : 2018-09-01 0 1,090 2018-07-28
177 ¼­¿ï 2018 Á¦ 13Â÷ ¼­¿ï´ëº´¿ø ±¹Á¦ ³úÁ¹Áß ½ÉÆ÷Áö¾ö : 2018-09-01 0 411 2018-07-28
176 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø The 8th Rapid Response Systems Symposium : 2018-09-01 0 642 2018-07-28
175 Á¦ÁÖ Á¦ÁÖµµÀÇ»çȸ 2018³â Áö¿ªÀÇ»ç´ë»ó ¿¬¼ö°­Á : 2018-09-01 0 476 2018-07-28
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷